We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 222 → 3 (-219)

99.54% less ownership

Funds ownership: 99.59% → 0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
217
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$341M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$335M
3
GCL
Glazer Capital LLC
New York
-$193M
4
Fidelity International
Fidelity International
Bermuda
-$142M
5
State Street
State Street
Massachusetts
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
201
Smartleaf Asset Management
Massachusetts
– -$5.45K -116 Closed
SPIA
202
Steward Partners Investment Advisory
New York
– -$4.7K -100 Closed
AF
203
Allworth Financial
California
– -$4.18K -89 Closed
HWP
204
Highline Wealth Partners
California
– -$2.91K -62 Closed
BC
205
Bayforest Capital
United Kingdom
– -$2.68K -57 Closed
PFBT
206
Parkside Financial Bank & Trust
Missouri
– -$2.54K -54 Closed
CIBC Private Wealth Group
207
CIBC Private Wealth Group
Georgia
– -$2.02K -43 Closed
WWM
208
Wolff Wiese Magana
California
– -$1.6K -34 Closed
GRP
209
Global Retirement Partners
California
– -$1.55K -33 Closed
FFA
210
Farther Finance Advisors
California
– -$1.46K -31 Closed
BIA
211
Bell Investment Advisors
California
– -$1.32K -28 Closed
BIG
212
Brooklyn Investment Group
New York
– -$1.32K -28 Closed
MPWT
213
MassMutual Private Wealth & Trust
Connecticut
– -$1.27K -27 Closed
BTI
214
Blue Trust Inc
Georgia
– -$987 -21 Closed
AAP
215
Arax Advisory Partners
Colorado
– -$517 -11 Closed
PWA
216
Physician Wealth Advisors
Utah
– -$423 -9 Closed
PS
217
Principal Securities
Iowa
– -$376 -8 Closed
TWD
218
True Wealth Design
Ohio
– -$329 -7 Closed
ANBT
219
American National Bank & Trust
Texas
– -$141 -3 Closed
5 6 7 8
9

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.